Chronic Spontaneous Urticaria Market is driven by Biologic Therapies Adoption
The Global Chronic Spontaneous Urticaria Market encompasses a range of therapeutic products designed to alleviate persistent hives and angioedema, primarily targeting autoimmune and inflammatory pathways. These products include second-generation antihistamines, omalizumab and emerging monoclonal antibody therapies that offer improved safety profiles, rapid symptom relief and enhanced patient...
0 Comentários 0 Compartilhamentos 68 Visualizações 0 Anterior